Use of proton MR spectroscopy and MR imaging to assess obesity

被引:16
|
作者
BaracNieto, M
Gupta, RK
机构
[1] Department of Pediatrics, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461
[2] Department of Physiology and Biophysics, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY 10461
来源
关键词
obesity; magnetic resonance spectroscopy; magnetic resonance imaging; nuclear magnetic resonance; body composition; body fat; abdominal fat; retroperitoneal fat; visceral fat; subcutaneous fat;
D O I
10.1002/jmri.1880060141
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We used H-1 MR spectroscopy and MR imaging at 9,4-T to quantify and localize fat and water in the abdominal regions of 12 lean, normal, and obese mice, The D2O dilution method which measures also the equilibrium plasma D2O concentration by H-2 MR spectroscopy was used to quantify body water and fat, In obese mice, the intensity of the fat H-1 resonance was about 120% that of the water 1H resonance, about threefold higher than its value (about 45%) in normal mice. In lean mice, the fat/water intensity ratio was about 1:4, about half that in normal mice. Total body water was similar in obese and normal mice (19.9 +/- 1.5 and 18.7 +/- 1.3 mt) despite their very different body weights (50.1 +/- 3.1 g and 30.2 +/- 3.1 g, respectively), but slightly lower in lean mice (14.8 +/- 1.2 mt water; 22.1 g +/- 2.0 g weight), Selective methylene-proton images showed marked accumulation of fat in the abdomen and the retroperitoneal and subcutaneous spaces of obese mice. Selective water-proton images allowed clear resolution of the renal cortex, medulla, papilla, and urinary pelvis. The readily measurable resonance intensity ratio of abdominal fat to water is a sensitive index by which to characterize obesity.
引用
收藏
页码:235 / 238
页数:4
相关论文
共 50 条
  • [1] Cerebral mucormycosis: proton MR spectroscopy and MR imaging
    Siegal, JA
    Cacayorin, ED
    Nassif, AS
    Rizk, D
    Galambos, C
    Levy, B
    Kennedy, D
    Visconti, J
    Perman, W
    MAGNETIC RESONANCE IMAGING, 2000, 18 (07) : 915 - 920
  • [2] Brain MR imaging and proton MR spectroscopy in cognitive impairment
    Weiss, U
    Bacher, R
    Vonbank, H
    Kemmler, G
    Lingg, A
    Marksteiner, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S375 - S376
  • [3] Metachromatic leukodystrophy - Diffusion MR imaging and proton MR spectroscopy
    Sener, RN
    ACTA RADIOLOGICA, 2003, 44 (04) : 440 - 443
  • [4] Lowe syndrome: Proton MR spectroscopy, and diffusion MR imaging
    Sener, RN
    JOURNAL OF NEURORADIOLOGY, 2004, 31 (03) : 238 - 240
  • [5] MR imaging and proton MR spectroscopy in adult Krabbe disease
    Farina, L
    Bizzi, A
    Finocchiaro, G
    Pareyson, D
    Sghirlanzoni, A
    Bertagnolio, B
    Savoiardo
    Naidu, S
    Singhal, BS
    Wenger, DA
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2000, 21 (08) : 1478 - 1482
  • [6] Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging, and proton MR spectroscopy
    Sener, RN
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2004, 25 (05) : 892 - 894
  • [7] Neuroaxonal dystrophy: Imaging, proton MR spectroscopy, and diffusion MR imaging findings
    Mutlu, H.
    Sildiroglu, H. O.
    Sonmez, G.
    Ozturk, E.
    Kizilkaya, E.
    JOURNAL OF NEURORADIOLOGY, 2006, 33 (03) : 207 - 208
  • [8] Perfusion MR imaging and proton MR spectroscopy of neoplasic brain tumors
    Cruz, LH
    Brandao, LA
    Martins, G
    Domingues, RC
    Provenzale, JM
    Domingues, RC
    RADIOLOGY, 2001, 221 : 134 - 134
  • [9] MR Imaging and proton MR spectroscopy of the brain in Behcet's disease
    Cellerini, M
    Bartolucci, M
    Mortilla, M
    Mascalchi, M
    Gobbi, FL
    Marchione, I
    Salvati, G
    Del Seppia, I
    Emmi, L
    RIVISTA DI NEURORADIOLOGIA, 2003, 16 (02): : 267 - 273
  • [10] MR imaging and proton MR spectroscopy in Japanese autosomal dominant leukodystrophy
    Nomoto, N.
    Wakata, N.
    Kurihara, T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 130 - 130